235 related articles for article (PubMed ID: 28982299)
21. PEG-aspargase and DEP regimen combination therapy for refractory Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis.
Wang J; Wang Y; Wu L; Zhang J; Lai W; Wang Z
J Hematol Oncol; 2016 Sep; 9(1):84. PubMed ID: 27613189
[TBL] [Abstract][Full Text] [Related]
22. Serum sCD25/ferritin ratio combined with MCP-1 is a valid predictor for identifying LAHS with HLH as the first manifestation.
Zou H; He L; Hue Z; Liu M; Yao S; Zhu Y; Wang Z; Wang Y
J Cancer Res Clin Oncol; 2023 Sep; 149(11):8521-8533. PubMed ID: 37093345
[TBL] [Abstract][Full Text] [Related]
23. Requirement for containing etoposide in the initial treatment of lymphoma associated hemophagocytic lymphohistiocytosis.
Song Y; Wang J; Wang Y; Wu L; Wang Z
Cancer Biol Ther; 2021 Dec; 22(10-12):598-606. PubMed ID: 34724875
[TBL] [Abstract][Full Text] [Related]
24. High concentration of miR-133 is a useful marker for the diagnosis of lymphoma- associated hemophagocytic syndrome.
Li W; Zhong Y; Shuang Y; Huang H; Huang Y; Yu L; Huang X
Cancer Biomark; 2017 Aug; 20(2):159-164. PubMed ID: 28869447
[TBL] [Abstract][Full Text] [Related]
25. Using etoposide + dexamethasone-based regimens to treat nasal type extranodal natural killer/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis.
Wei L; Yang L; Cong J; Ye J; Li X; Yao N; Yang J; Ding J; Wang J
J Cancer Res Clin Oncol; 2021 Mar; 147(3):863-869. PubMed ID: 33025280
[TBL] [Abstract][Full Text] [Related]
26. The Prognostic Significance of Beta2 Microglobulin in Patients with Hemophagocytic Lymphohistiocytosis.
Jiang T; Ding X; Lu W
Dis Markers; 2016; 2016():1523959. PubMed ID: 27110054
[TBL] [Abstract][Full Text] [Related]
27. [Lymphoma-associated hemophagocytic syndrome in Japan].
Takahashi N; Chubachi A; Miura I; Nakamura S; Miura AB
Rinsho Ketsueki; 1999 Jul; 40(7):542-9. PubMed ID: 10483136
[TBL] [Abstract][Full Text] [Related]
28. Identification of clinical features of lymphoma-associated hemophagocytic syndrome (LAHS): an analysis of 69 patients with hemophagocytic syndrome from a single-center in central region of China.
Li F; Li P; Zhang R; Yang G; Ji D; Huang X; Xu Q; Wei Y; Rao J; Huang R; Chen G
Med Oncol; 2014 Apr; 31(4):902. PubMed ID: 24610542
[TBL] [Abstract][Full Text] [Related]
29. A clinical study of 21 patients with hemophagocytic syndrome in 295 cases diagnosed with nasal type, extranodal nature killer/T cell lymphoma.
Li N; Zhang L; Liu J; Zhang J; Weng HW; Zhuo HY; Zou LQ
Cancer Biol Ther; 2017 Apr; 18(4):252-256. PubMed ID: 28278074
[TBL] [Abstract][Full Text] [Related]
30. [The diagnostic value of flow cytometry in patients with lymphoma associated hemophagocytic syndrome].
Zhang WL; Xu L; Zhang Q; Zhong FL; Dai J; Feng J; Sun LH; Xu HC; Xie WY; Zhang HY
Zhonghua Nei Ke Za Zhi; 2020 Dec; 59(12):976-981. PubMed ID: 33256339
[No Abstract] [Full Text] [Related]
31. [Clinical analysis of 14 patients with lymphoma associated hemophagocytic syndrome].
Wang JS; Wang Z; Wu L; Tian LP; Chen X
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Oct; 17(5):1352-5. PubMed ID: 19840482
[TBL] [Abstract][Full Text] [Related]
32. [Lymphoma-associated hemophagocytic syndrome(LAHS)].
Takahashi N
Nihon Rinsho; 2000 Mar; 58(3):665-8. PubMed ID: 10741143
[TBL] [Abstract][Full Text] [Related]
33. Allogeneic hematopoietic stem-cell transplantation for adult and adolescent hemophagocytic lymphohistiocytosis: a single center analysis.
Fu L; Wang J; Wei N; Wu L; Wang Y; Huang W; Zhang J; Liu J; Wang Z
Int J Hematol; 2016 Nov; 104(5):628-635. PubMed ID: 27431489
[TBL] [Abstract][Full Text] [Related]
34. Clinical and genetic characterization of Epstein-Barr virus-associated T/NK-cell lymphoproliferative diseases.
Luo H; Liu D; Liu W; Jin J; Bi X; Zhang P; Gu J; Zheng M; Xiao M; Liu X; Zhou J; Wang QF
J Allergy Clin Immunol; 2023 Apr; 151(4):1096-1109. PubMed ID: 36423698
[TBL] [Abstract][Full Text] [Related]
35. Clinical relevance of three subtypes of primary sinonasal lymphoma characterized by immunophenotypic analysis.
Kim GE; Koom WS; Yang WI; Lee SW; Keum KC; Lee CG; Suh CO; Hahn JS; Roh JK; Kim JH
Head Neck; 2004 Jul; 26(7):584-93. PubMed ID: 15229900
[TBL] [Abstract][Full Text] [Related]
36. The Clinical Significance and Prognostic Role of Whole-Blood Epstein-Barr Virus DNA in Lymphoma-Associated Hemophagocytic Lymphohistiocytosis.
Zhang J; Qin S; Jin Z; Chen Q; Xing L; Qiu T; Xia Y; Liang J; Zhu H; Wang L; Fan L; Xu W; Li J; Miao Y
J Clin Immunol; 2023 Aug; 43(6):1302-1310. PubMed ID: 37093406
[TBL] [Abstract][Full Text] [Related]
37. [Clinical analysis and follow-up study of Epstein-Barr virus associated-hemophagocytic lymphohistiocytosis in childhood].
Lu G; Xie ZD; Shen KL; Wu RH; Jin YK; Yang S; Liu CY
Zhonghua Er Ke Za Zhi; 2010 Feb; 48(2):121-6. PubMed ID: 20426937
[TBL] [Abstract][Full Text] [Related]
38. Elevation of CD16
Wang J; Han W; Gao Z; Wang Y; Wu L; Zhang J; Lai W; Wang Z
Hematology; 2017 Sep; 22(8):477-483. PubMed ID: 28413901
[TBL] [Abstract][Full Text] [Related]
39. Adult onset hemophagocytic lymphohistiocytosis prognosis is affected by underlying disease and coexisting viral infection: analysis of a single institution series of 35 patients.
Cattaneo C; Oberti M; Skert C; Passi A; Farina M; Re A; Tozzi P; Borlenghi E; Rossi G
Hematol Oncol; 2017 Dec; 35(4):828-834. PubMed ID: 27255829
[TBL] [Abstract][Full Text] [Related]
40. Clinical characteristics of extranodal NK/T-cell lymphoma-associated hemophagocytic lymphohistiocytosis.
Liu YZ; Bi LQ; Chang GL; Guo Y; Sun S
Cancer Manag Res; 2019; 11():997-1002. PubMed ID: 30774427
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
